Skip To Content
CPPD Update 2019: Hepatitis C is a Course

CPPD Update 2019: Hepatitis C

Started Sep 17, 2019
1.5 credits


Full course description

Three Hepatitis C medications were in the Top 10 Medications reimbursed by PharmaCare in 2016/17.
This program will provide practical information on how to manage patients with chronic hepatitis C receiving Direct Acting Antiviral (DAA) regimens. Topics will include patient screening, therapy selection/optimization, common drug-drug interactions, medication coverage, and mini case vignettes. 

Program: Hepatitis C Update: How To Manage HCV Therapy With The Next Generation Direct Acting Antivirals

Presenter: Trana Hussaini, BSc(Pharm), PharmD, ACPR, RPh 

# of CEUs: 1.5 (BC-2019-009-ISP)

On the learner transcript, the number of credits is equivalent to the number of CEUs. 

Sign up for this course today!